News

Izotropic CEO Interview - Clinical Trial & CRO Updates! (CSE:IZO)

Izotropic CEO Dr. John McGraw joins Justin today to give updates on how clinical trials are going for the company. Dr. John McGraw explains to the audience what a CRO is, Izotropic chose Icon as the company's CRO after a lengthy interview process. These are some of the steps Izotropic has to take to get the company to commercialization.
IZO
July 27, 2022


Izotropic CEO Dr. John McGraw joins Justin today to give updates on how clinical trials are going for the company. Dr. John McGraw explains to the audience what a CRO is, Izotropic chose Icon as the company's CRO after a lengthy interview process. These are some of the steps Izotropic has to take to get the company to commercialization.

Izotropic Corporation is the only publicly-traded company commercializing a dedicated breast CT imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers.IzoView produces high resolution breast images in true 3D with low radiation dose levels,and is ideal for imaging patients with dense breast tissue. A single 10 second scan acquires approximately 500 images, without painful breastcompression or continual technician breast handling, providing a more comfortable patient experience.

https://izocorp.com‍

CSE:IZO | OTCQB:IZOZF